BATM Advanced Communications Ltd. is a technology company specializing in networking and diagnostics solutions. The firm develops and supplies hardware and software systems for telecommunications operators, enterprises and public-sector entities, alongside a growing portfolio of life-science and medical testing products. BATM’s offerings are designed to enhance network performance, secure data transmission and streamline diagnostic workflows.
In its communications segment, BATM provides physical-layer and network-level appliances that enable broadband access, carrier Ethernet transport and cybersecurity services. Its product range includes optical transport equipment, network edge devices, broadband remote access servers and deep-packet inspection solutions, which are tailored to meet the requirements of service providers, data centers and critical infrastructure operators.
BATM’s healthcare division focuses on molecular diagnostics and point-of-care testing. The company develops platforms and consumables for nucleic acid amplification testing, including laboratory automation systems and handheld rapid detection kits. These products support clinical laboratories, hospitals and public health agencies in areas such as infectious disease screening, blood-bank testing and environmental monitoring.
Founded in the early 1980s and headquartered in Petah Tikva, Israel, BATM has expanded its footprint across Europe, North America and Asia. The company collaborates with international partners, research institutions and channel resellers to deliver integrated solutions globally. BATM is listed on the London Stock Exchange’s AIM market and trades in the U.S. OTC markets under the ticker BTAVF.
AI Generated. May Contain Errors.